Europäische Union - Deutsch - EMA (European Medicines Agency)

sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - immunsuppressiva - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - sutimlimabum - solution pour perfusion - sutimlimabum 50 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, polysorbatum 80, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 3.45 mg. - traitement de l’anémie hémolytique des patients adultes atteints de la maladie des agglutinines froides - biotechnologika